[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock rises Monday, still underperforms market",
    "summary": "Bristol Myers Squibb Co. stock rises Monday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=b763b8f736669b163367f9ca104f3c29c8b891c7434c045d25424565cc954a8f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734972060,
      "headline": "Bristol Myers Squibb Co. stock rises Monday, still underperforms market",
      "id": 132148492,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock rises Monday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=b763b8f736669b163367f9ca104f3c29c8b891c7434c045d25424565cc954a8f"
    }
  },
  {
    "ts": null,
    "headline": "BMS sees success in Phase III Sotyktu psoriatic arthritis trials",
    "summary": "Both trials recruited patients with psoriatic arthritis who had not previously received biologic disease-modifying antirheumatic drugs.",
    "url": "https://finnhub.io/api/news?id=4c492c4e8cb8dda8ad442dd90907499d67ddfabf4310b30776465e277a0d51a5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734970365,
      "headline": "BMS sees success in Phase III Sotyktu psoriatic arthritis trials",
      "id": 132120367,
      "image": "https://live-b2b-gdm-figaro1.pantheonsite.io/wp-content/uploads/sites/22/2024/12/New-Project-7.jpg",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Both trials recruited patients with psoriatic arthritis who had not previously received biologic disease-modifying antirheumatic drugs.",
      "url": "https://finnhub.io/api/news?id=4c492c4e8cb8dda8ad442dd90907499d67ddfabf4310b30776465e277a0d51a5"
    }
  },
  {
    "ts": null,
    "headline": "Monopar: Radiopharmaceutical Company With 2 Radioisotope Development Pathways",
    "summary": "Learn about the promising Monopar Therapeutics Inc. MNPR-101 treatment targeting solid tumors and how it aims to reduce investor risk. Click for more on NMPR.",
    "url": "https://finnhub.io/api/news?id=36bc41a3944ccdc35f83be038b4d5b405c1479bc0e3e2f348b2e1b7d3e2e438a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734963820,
      "headline": "Monopar: Radiopharmaceutical Company With 2 Radioisotope Development Pathways",
      "id": 132122209,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2166352596/image_2166352596.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Learn about the promising Monopar Therapeutics Inc. MNPR-101 treatment targeting solid tumors and how it aims to reduce investor risk. Click for more on NMPR.",
      "url": "https://finnhub.io/api/news?id=36bc41a3944ccdc35f83be038b4d5b405c1479bc0e3e2f348b2e1b7d3e2e438a"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Announces Positive Topline Results from Two Pivotal Phase 3 Trials Evaluating Sotyktu (deucravacitinib) in Adults with Psoriatic Arthritis",
    "summary": "PRINCETON, N.J., December 23, 2024--BMS Announces Positive Topline Results from Two Pivotal Phase 3 Trials Evaluating Sotyktu (deucravacitinib) in Adults with Psoriatic Arthritis",
    "url": "https://finnhub.io/api/news?id=595cb2043a7b96ca9daaf7dc57ad78054df0d481d6ba0066fcba7cf2b8bea54e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734955140,
      "headline": "Bristol Myers Squibb Announces Positive Topline Results from Two Pivotal Phase 3 Trials Evaluating Sotyktu (deucravacitinib) in Adults with Psoriatic Arthritis",
      "id": 132119963,
      "image": "https://s.yimg.com/ny/api/res/1.2/RtleBx1fueEILaFY6MHi0g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xNjU-/https://media.zenfs.com/en/business-wire.com/826de3d76d1d59fe82a5c4ae88476b60",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., December 23, 2024--BMS Announces Positive Topline Results from Two Pivotal Phase 3 Trials Evaluating Sotyktu (deucravacitinib) in Adults with Psoriatic Arthritis",
      "url": "https://finnhub.io/api/news?id=595cb2043a7b96ca9daaf7dc57ad78054df0d481d6ba0066fcba7cf2b8bea54e"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer",
    "summary": "PRINCETON, N.J., December 23, 2024--Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult...",
    "url": "https://finnhub.io/api/news?id=42313cd9b8a07b14ac8a4244c98d0394ca1889d39395589ae0bb719094f1fd8b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734954300,
      "headline": "Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer",
      "id": 132119964,
      "image": "https://s.yimg.com/ny/api/res/1.2/IuxvxAPhJLg7aHnvfs4bnw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xNjU-/https://media.zenfs.com/en/business-wire.com/82ed570fef14199aab0ee7b836f43fc1",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., December 23, 2024--Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult...",
      "url": "https://finnhub.io/api/news?id=42313cd9b8a07b14ac8a4244c98d0394ca1889d39395589ae0bb719094f1fd8b"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Phase 3 Sotyktu Studies Hit Goals in Psoriatic Arthritis",
    "summary": "By Colin Kellaher Bristol Myers Squibb said a pair of late-stage studies of its plaque psoriasis drug Sotyktu met their key goals in adults with active psoriatic arthritis. Bristol Myers on...",
    "url": "https://finnhub.io/api/news?id=9dd1d6512e3a147d3b5a4facda02a0df3c0eae90b65f0e750d5586c03bda3323",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734939733,
      "headline": "Bristol Myers Phase 3 Sotyktu Studies Hit Goals in Psoriatic Arthritis",
      "id": 132117915,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "By Colin Kellaher Bristol Myers Squibb said a pair of late-stage studies of its plaque psoriasis drug Sotyktu met their key goals in adults with active psoriatic arthritis. Bristol Myers on...",
      "url": "https://finnhub.io/api/news?id=9dd1d6512e3a147d3b5a4facda02a0df3c0eae90b65f0e750d5586c03bda3323"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers: positive data in psoriatic arthritis",
    "summary": "Bristol Myers Squibb reports positive results from POETYK PsA-1 and POETYK PsA-2, the pivotal Phase 3 trials evaluating the efficacy and safety of Sotyktu in adults with active psoriatic arthritis....",
    "url": "https://finnhub.io/api/news?id=1143c431681522144c7b27b86ca6656464ae1d2846e598e5c5c7545a31b300f4",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734939136,
      "headline": "Bristol Myers: positive data in psoriatic arthritis",
      "id": 132117858,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Bristol Myers Squibb reports positive results from POETYK PsA-1 and POETYK PsA-2, the pivotal Phase 3 trials evaluating the efficacy and safety of Sotyktu in adults with active psoriatic arthritis....",
      "url": "https://finnhub.io/api/news?id=1143c431681522144c7b27b86ca6656464ae1d2846e598e5c5c7545a31b300f4"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb: received EU approval",
    "summary": "Bristol Myers Squibb receives European Commission approval for Opdivo® plus Yervoy® for the first-line treatment of adult patients with metastatic colorectal cancer with high microsatellite...",
    "url": "https://finnhub.io/api/news?id=1283347ddb1024a0c5e8563224441ad7ad97ba500562869647a66e0aac4a6298",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734937449,
      "headline": "Bristol Myers Squibb: received EU approval",
      "id": 132117567,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Bristol Myers Squibb receives European Commission approval for Opdivo® plus Yervoy® for the first-line treatment of adult patients with metastatic colorectal cancer with high microsatellite...",
      "url": "https://finnhub.io/api/news?id=1283347ddb1024a0c5e8563224441ad7ad97ba500562869647a66e0aac4a6298"
    }
  },
  {
    "ts": null,
    "headline": "Lazard Managed Equity Volatility Portfolio Q3 2024 Commentary",
    "summary": "During Q3 2024, the Lazard Global Managed Volatility Equity Portfolio underperformed the MSCI World Index (net). Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=767d37005ddf5b16b32196b3e6d59764f7709993745f3174e433e3b838fed0f8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734915900,
      "headline": "Lazard Managed Equity Volatility Portfolio Q3 2024 Commentary",
      "id": 132115538,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2158857051/image_2158857051.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "During Q3 2024, the Lazard Global Managed Volatility Equity Portfolio underperformed the MSCI World Index (net). Click here to read the full commentary.",
      "url": "https://finnhub.io/api/news?id=767d37005ddf5b16b32196b3e6d59764f7709993745f3174e433e3b838fed0f8"
    }
  }
]